NRx Pharmaceuticals Ownership | Who Owns NRx Pharmaceuticals?
NRx Pharmaceuticals Ownership Summary
NRx Pharmaceuticals is owned by 18.25% institutional investors, 15.88% insiders, and 65.87% retail investors. Anson funds management lp is the largest institutional shareholder, holding 9.78% of NRXP shares. AdvisorShares Psychedelics ETF is the top mutual fund, with 1.45% of its assets in NRx Pharmaceuticals shares.
NRXP Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | NRx Pharmaceuticals | 18.25% | 15.88% | 65.87% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 307.00% | 11.11% | -218.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Anson funds management lp | 1.60M | 9.78% | $5.23M |
Advisorshares investments | 263.80K | 1.61% | $859.98K |
Blackrock funding, inc. /de | 64.40K | 0.39% | $209.94K |
Marshall wace, llp | 33.38K | 0.20% | $108.83K |
Raymond james financial | 2.57K | 0.02% | $8.38K |
Larson financial group | 22.00 | 0.00% | $72.00 |
Townsquare capital | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Anson funds management lp | 1.60M | 0.75% | $5.23M |
Advisorshares investments | 263.80K | 0.15% | $859.98K |
Marshall wace, llp | 33.38K | 0.00% | $108.83K |
Raymond james financial | 2.57K | - | $8.38K |
Townsquare capital | - | - | - |
Larson financial group | 22.00 | - | $72.00 |
Blackrock funding, inc. /de | 64.40K | - | $209.94K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Anson funds management lp | 1.60M | 0.75% | 425.91K |
Blackrock funding, inc. /de | 64.40K | - | 35.33K |
Raymond james financial | 2.57K | - | 2.57K |
Larson financial group | 22.00 | - | - |
Townsquare capital | - | - | -15.04K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Marshall wace, llp | 33.38K | 0.00% | -55.70K |
Advisorshares investments | 263.80K | 0.15% | -23.00K |
Townsquare capital | - | - | -15.04K |
Larson financial group | 22.00 | - | - |
Raymond james financial | 2.57K | - | 2.57K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Raymond james financial | 2.57K | - | 2.57K | $8.38K |
Sold Out
Holder | Change |
---|---|
Townsquare capital | -15.04K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 25 | 8.70% | 2,994,368 | 32.46% | 18 | 9.62% | 15 | 50.00% | 4 | -33.33% |
Mar 31, 2025 | 23 | -14.81% | 2,260,524 | 115.57% | 13 | 13.86% | 10 | -37.50% | 6 | 200.00% |
Dec 31, 2024 | 27 | 28.57% | 1,048,642 | 46.80% | 9 | 23.53% | 16 | 77.78% | 2 | -50.00% |
Sep 30, 2024 | 21 | - | 714,327 | 39.97% | 6 | 27.64% | 9 | 80.00% | 4 | -73.33% |
Jun 30, 2024 | 21 | -34.38% | 510,359 | -86.33% | 4 | 27.29% | 5 | -37.50% | 15 | 87.50% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
AdvisorShares Psychedelics ETF | 283.15K | 1.45% | - |
Vanguard Total Stock Mkt Idx Inv | 246.38K | 1.26% | -5.38K |
Vanguard US Total Market Shares ETF | 193.42K | 1.23% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 144.48K | 0.74% | -41.40K |
Fidelity Extended Market Index | 74.71K | 0.38% | -195.00 |
KoAct US Brain Treatment Active | 41.02K | 0.26% | 41.02K |
iShares Micro-Cap ETF | 32.35K | 0.17% | - |
Fidelity Total Market Index | 31.10K | 0.16% | 12.72K |
Fidelity Nasdaq Composite Index | 21.98K | 0.11% | 21.98K |
Fidelity Series Total Market Index | 19.86K | 0.10% | -818.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 17, 2024 | Javitt Jonathan C | Chairman and Chief Scientist | Buy | $46.80K |
Aug 30, 2023 | Gorovitz Aaron | - | Buy | $11.20K |
Aug 30, 2023 | Hurvitz Chaim | - | Buy | $20.13K |
Aug 23, 2023 | Javitt Jonathan C | Chief Scientist | Buy | $33.00K |
Aug 22, 2023 | Javitt Jonathan C | Chief Scientist | Buy | $64.40K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 1 | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
2023 Q3 | 4 | - |
NRXP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools